Skip to main content
SpringerLink
Log in

Therapie des Herpes zoster

Therapy of herpes zoster

  • Leserfragen
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Ahmad K (2002) Vaccination with varicella protects against zoster infection. Lancet Oncol 3: 523

    Article  PubMed  Google Scholar 

  2. Appelbaum E, Rachelson MH, Dolgopol VB (1953) Varicella encephalitis. Am J Med 15: 223–230

    Article  PubMed  CAS  Google Scholar 

  3. Austin RB (2000) Progressive outer retinal necrosis syndrome: a comprehensive review of its clinical presentation, relationship to immune system status, and management. Clin Eye Vis Care 12: 119–129

    Article  PubMed  Google Scholar 

  4. Balfour HH (1988) Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management. Am J Med 85(2A): 68–73

    Article  PubMed  Google Scholar 

  5. Beutner KR, Friedman DJ, Forszpaniak C et al. (1995) Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 39: 1546–1553

    PubMed  CAS  Google Scholar 

  6. Boiardi A, Ferrante P, Porta E et al. (1986) Herpes zoster myelitis: nervous system complications. Ital J Neurol Sci 7: 617–622

    Article  PubMed  CAS  Google Scholar 

  7. Breton G, Fillet AM, Katlama C et al. (1998) Acyclovir-resistant herpes zoster in human immunodeficiency virus-infected patients: results of foscarnet therapy. Clin Infect Dis 27: 1525–1527

    Article  PubMed  CAS  Google Scholar 

  8. Breuer J (2001) Vaccination to prevent varicella and shingles. J Clin Pathol 54: 743–747

    PubMed  CAS  Google Scholar 

  9. Coudeville L, Brunot A, Szucs TD, Dervaux B (2005) The economic value of childhood varicella vaccination in France and Germany. Value Health 8: 209–222

    Article  PubMed  Google Scholar 

  10. Dworkin RH, Johnson RW, Breuer J et al. (2007) Recommendations for the management of herpes zoster. Clin Infect Dis 44: 1–26

    Article  Google Scholar 

  11. Einsele H, Bertz H, Beyer J et al. (2003) Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies – guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82: 175–185

    Article  Google Scholar 

  12. Ernst ME, Santee JA, Klepser TB (1998) Oral corticosteroids for pain associated with herpes zoster. Ann Pharmacother 32: 1099–1103

    Article  PubMed  CAS  Google Scholar 

  13. Gilden D (2004) Varicella zoster virus and central nervous system syndromes. Herpes 11: 89A–94A

    PubMed  Google Scholar 

  14. Gnann JW (2002) Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 186: 91–98

    Article  Google Scholar 

  15. Gross G, Schofer H, Wassilew S et al. (2003) Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol 26: 277–289

    Article  PubMed  CAS  Google Scholar 

  16. Hope-Simpson RE (1965) The nature of herpes zoster: a long-term study and a new hypothesis. J R Soc Med 58: 9–20

    CAS  Google Scholar 

  17. Huff JC (1988) Antiviral treatment in chickenpox and herpes zoster. J Am Acad Dermatol 18: 204–206

    Article  PubMed  CAS  Google Scholar 

  18. Hulsse C (2004) STIKO (established vaccination committee) recommends varicella vaccination for all children: are chickenpox really so risky? MMW Fortschr Med 146: 11

    PubMed  Google Scholar 

  19. Joffee B (1960) Adult chickenpox pneumonia. Calif Med 92: 164–165

    PubMed  CAS  Google Scholar 

  20. Kaplan JE, Masur H, Holmes KK (2002) Guidelines for preventing opportunistic infections among HIV-infected persons – 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 14: 1–52

    Google Scholar 

  21. Kennedy PG, Barrass JD, Graham DI, Clements GB (1990) Studies on the pathogenesis of neurological diseases associated with Varicella-Zoster virus. Neuropathol Appl Neurobiol 16: 305–316

    Article  PubMed  CAS  Google Scholar 

  22. Kinishi M, Amatsu M, Mohri M et al. (2001) Acyclovir improves recovery rate of facial nerve palsy in ramsay hunt syndrome. Auris Nasus Larynx 28: 223–226

    Article  PubMed  CAS  Google Scholar 

  23. Ljungman P, Lonnqvist B, Ringden O et al. (1989) A randomized trial of oral versus intravenous acyclovir for treatment of herpes zoster in bone marrow transplant recipients. Nordic Bone Marrow Transplant Group. Bone Marrow Transplant 4: 613–615

    PubMed  CAS  Google Scholar 

  24. Madkan VK, Arora A, Babb-Tarbox M et al. (2007) Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older. J Cutan Med Surg 11: 89–98

    PubMed  CAS  Google Scholar 

  25. Morgan-Capner P, Crowcroft NS (2002) Guidelines on the management of, and exposure to, rash illness in pregnancy (including consideration of relevant antibody screening programmes in pregnancy). Commun Dis Public Health 5: 59–71

    PubMed  CAS  Google Scholar 

  26. Murakami S, Hato N, Horiuchi J et al. (1997) Treatment of Ramsay Hunt syndrome with acyclovir-prednisone: significance of early diagnosis and treatment. Ann Neurol 41: 353–357

    Article  PubMed  CAS  Google Scholar 

  27. Sandherr M, Einsele H, Hebart H et al. (2006) Antiviral prophylaxis in patients with haematological malignancies and solid tumours: guidelines of the infectious diseases working party (AGIHO) of the German Society for Hematology and Oncology (DGHO). Ann Oncol 17: 1051–1059

    Article  PubMed  CAS  Google Scholar 

  28. Shafran SD, Tyring SK, Ashton R et al. (2004) Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial. J Clin Virol 29: 248–253

    Article  PubMed  CAS  Google Scholar 

  29. Sullivan KM, Dykewicz CA, Longworth DL et al.; Centers for Disease Control and Prevention; Infectious Diseases Society of America; American Society for Blood and Marrow Transplantation Practice Guidelines and beyond (2001) Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology Am Soc Hematol Educ Program: 392–421

    Google Scholar 

  30. Sweeney CJ, Gilden DH (2001) Ramsay hunt syndrome. J Neurol Neurosurg Psychiatry 71: 149–154

    Article  PubMed  CAS  Google Scholar 

  31. Tyring S, Barbarash RA, Nahlik JE et al. (1995) Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 123: 89–96

    PubMed  CAS  Google Scholar 

  32. Tyring S, Belanger R, Bezwoda W et al. (2001) A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients. Cancer Invest 19: 13–22

    Article  PubMed  CAS  Google Scholar 

  33. United Kingdom Advisory Group on Chickenpox (1998) Varicella supplement 1998 and consensus guidelines for management. J Infect 36: 1–83

    Google Scholar 

  34. Wassilew SW, Wutzler P (2003) Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study. Antiviral Res 59: 49–56

    Article  PubMed  CAS  Google Scholar 

  35. Whitley RJ, Weiss H, Gnann JW Jr et al. (1996) Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The national institute of allergy and infectious diseases collaborative antiviral study group. Ann Intern Med 125: 376–383

    PubMed  CAS  Google Scholar 

  36. Wood MJ, Johnson RW, McKendrick MW et al. (1994) A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 330: 896–900

    Article  PubMed  CAS  Google Scholar 

  37. Zambarakji HJ, Obi AA, Mitchell SM (2002) Successful treatment of varicella zoster virus retinitis with aggressive intravitreal and systemic antiviral therapy. Ocul Immunol Inflamm 10: 41–46

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt in Bezug auf Vakzinierungen besteht.

Author information

Authors and Affiliations

  1. III. Medizinische Klinik und Poliklinik, Klinikum Johannes Gutenberg Universität, Mainz, Langenbeckstraße 1, 55101, Mainz, Deutschland

    A.J. Ullmann

Authors
  1. A.J. Ullmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A.J. Ullmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ullmann, A. Therapie des Herpes zoster. Internist 49, 887–890 (2008). https://doi.org/10.1007/s00108-008-2174-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-008-2174-0

Search

Navigation